An early clinical trial of BCX4161 in patients with hereditary angioedema compared to treatment with placebo

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-002319-82

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the effect of prophylactic BCX4161 as measured by the frequency of attacks in subjects with hereditary angioedema (HAE)


Critère d'inclusion

  • hereditary angioedema